Sino-Biocan(Shanghai) Biotech

About us

Founded in

2013
Detached building

5000M²
Production workshop

3000M²
Annual equipment production

3000Unit
Annual consumable production

200,000Set
Annual liquid product

600,000Bottle

Sino-Biocan (Shanghai) Biotech Ltd is an automated, modularized, closed cell production platform provider in cell & gene therapy field, providing total solution of smart tools innovation and service, devoting to be the industry leader integrating R & D, business development, techinical service, customization and production.

Sino-Biocan has developed a GMP-grade product family of fully closed, modularized, continuous cell preparation tools, as well as consumables and liquid solution, covering processes such as automated cell separation, culture, cell concentration, washing and formulation filling, cryopreservation and recovery, widely applied in cell and gene drug development, CDMO, medical and pharmaceutical stem cell preparation and application, cord blood bank management and cell storage, etc. We can also provide modular splicing of different GMP processes according to specific customer requirements for different pipelines, to realize the rapid, efficient and differentiated customization of series products of cell preparation tools.

Learn more

Products

CELL-VOR Automated Cell Processing System

LEARN MORE

CELL-WAV Automated Cell Expansion System

LEARN MORE

Super CELL-VOR Automated High Volume Cell Concentration System

LEARN MORE

CELL-COL Automated Cell Recovery System

LEARN MORE

Learn more >

Services

Solutions

Learn more

Cell Recovery

Learn more

Cell Concentration

Learn more

Cell Expansion

Shanghai Factory

Sino-Biocan Biotech (Shanghai) Ltd. is the wholly owned subsidiary of Sino-Biocan, located in Shanghai Lingang Nanqiao Science and Technology City. With a total area of 7600㎡, it includes GMP-grade consumable clean workshop, liquid clean workshop, equipment production workshop, cell & gene therapy process research lab, equipment R&D lab, high level QC center, high level low-temperature and room-temperature warehouse, reaching production scale of 200,000 sets of consumables, 600,000 bottles of liquid reagents and 3,000 sets of equipment per year for cell & gene therapy preparation. In 2024, Sino-Biocan will expand the second-phase production base of more than 14,000㎡, intending to make it a leading production base for cell & gene therapy intelligent tools in China.

5000㎡

Detached building
3000㎡

Production workshop
Building 15, Lingang Nanqiao Technology City

GMP Consumables Centre

Disposable cell separators
Disposable cell cryopreservation bags
Disposable cell culture bags
Magnetic cell sorting columns

Clean Equipment Centre

Cell Separation Equipment
Cell Expansion equipment
Cell Concentration Equipment
Cell Cryopreservation Equipment
Cell Recovery Equipment

GMP Liquid Centre

Cell culture media
Cell cryopreservation solutions
Magnetic beads

Learn more

News

Sino-Biocan has established a new factory in Jiaxing, Zhejiang, to produce consumables and liquid products of GMP grade

On April 27, 2024, Sino-Biocan (Jiaxing) Biomedical Devices Co., Ltd. held a groundbreaking ceremony at Xitang, Jiaxing, China, marking a significant milestone in the company's development.

2024-04-28

Sino-Biocan together with representatives from Chulalongkorn University of Thailand exemplifies their resolute determination in expanding into international markets

On April 25, 2024, Ms. Wei Dongbing, Chairwoman of Sino-Biocan Biotech Ltd., Professor Nattiya Hirankarn, Vice Dean of the Faculty of Medicine of Chulalongkorn University, Thailand, and Dr. Supannikar Tawinwung, Deputy Director of the Cell Immunology Research Laboratory, together visited the Institute of Hematology and Blood Diseases Hospital of the Chinese Academy of Medical Sciences (IHCAMS) in collaboration with Juventas Cell Therapy Ltd., a subsidiary of He Yuan Bio-technology (Tianjin) Co., Ltd. They engaged in a cordial exchange and delved into the possibilities of future close collaborations.

2024-04-26

Sino-Biocan Completes Nearly Hundred Million RMB in Series B Financing to Provide High-Quality Fully Automatic Cell Preparation Systems for the Global Market

Sino-Biocan (Shanghai) Biotech Ltd. recently completed nearly a hundred million RMB in Series B financing. The raised funds will be primarily used to establish a modern production system, enhance overall research and development capabilities, and obtain global registration certification, aiming to rapidly expand into key global markets.

2024-03-27

Sino-Biocan has recently completed a Series A round of funding

Sino-Biocan(Beijing) Biotech Ltd(hereinafter referred to as “Sino-Biocan”) has recently completed a Series A round of funding of nearly RMB 100 million,led by Grand Flight Investment and continued by

2022-03-15

Sino-Biocan cell preparation tools production base inaugurated in Shanghai

Sino-Biocan cell preparation tools production base inaugurated in Shanghai

2021-11-18

Sino-Biocan has completed an angel round of funding in the tens of millions of dollars.

Sino-Biocan(Shanghai) Biotech Ltd has completed an angel round of funding in the tens of millions of dollars, with exclusive investment from Sinovation Ventures.

2021-10-06

Learn more